A retrospective study of the efficacy of combined EGFRTKI plus VEGF inhibitor/cytotoxic therapy vs. EGFRTKI monotherapy for PDL1positive EGFRmutant nonsmall cell lung cancer: North Japan Lung Cancer Study Group 2202.
Oncol Lett
; 26(2): 334, 2023 Aug.
Article
in En
| MEDLINE
| ID: mdl-37427337
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Clinical_trials
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
Oncol Lett
Year:
2023
Document type:
Article
Affiliation country:
Japón
Country of publication:
Grecia